News
After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...
Of multiple employees accused of sexual abuse at a now-closed Florida juvenile justice center, a lawsuit brought by five survivors says one staffer had girls who objected to abuse, or ...
The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off ...
11h
Best Life on MSNOzempic Causes Vision Loss, Growing Number of Lawsuits Claim: "There’s Another Side to This Drug"I t’s hard to argue that the introduction of drugs like Ozempic has been anything short of revolutionary for people looking ...
Amble Health's website states it is a platform connecting patients to licensed healthcare professionals online, who can ...
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
Lawsuits are piling up as weight-loss drug users report losing their sight: ‘I definitely wouldn’t have taken it’ - Edward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results